Bisphosphonate treatment of osteoporosis

被引：76
作者：
Watts, NB
机构：
[1] Univ Cincinnati, Bone Hlth & Osteoporosis Ctr, Cincinnati, OH 45219 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
CLINICS IN GERIATRIC MEDICINE | 2003年 / 19卷 / 02期
关键词：
D O I：
10.1016/S0749-0690(02)00069-1
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Bisphosphonates have proven effectiveness for the prevention and treatment of osteoporosis in women and men. Currently, two bisphosphonates are approved by the US Food and Drug Administration for use in osteoporosis. Several others are on the market for other indications and are sometimes used "off label" for treatment of osteoporosis. Although bisphosphonates are effective for the management of osteoporosis, it is important that patients treated with bisphosphonates engage in weight-bearing exercise and have adequate intake of calcium and vitamin D.
引用
收藏
页码：395 / +
页数：21
相关论文
共 160 条
[1]  
Abdelmalek MF, 1996, AM J GASTROENTEROL, V91, P1282
[2]   Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].
Adachi, JD ;
Bensen, WG ;
Brown, J ;
Hanley, D ;
Hodsman, A ;
Josse, R ;
Kendler, DL ;
Lentle, B ;
Olszynski, W ;
SteMarie, LG ;
Tenenhouse, A ;
Chines, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387
[3]   Tolerability of risedronate in postmenopausal women intolerant of alendronate [J].
Adachi, JD ;
Adami, S ;
Miller, PD ;
Olszynski, WP ;
Kendler, DL ;
Silverman, SL ;
Licata, AA ;
Li, Z ;
Gomez-Panzani, E .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 13 (05) :347-354
[4]   THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].
ADAMI, S ;
BHALLA, AK ;
DORIZZI, R ;
MONTESANTI, F ;
ROSINI, S ;
SALVAGNO, G ;
LOCASCIO, V .
CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331
[5]  
Adami S, 2002, OSTEOPOROSIS INT, V13, pS14
[6]   DURATION OF THE EFFECTS OF INTRAVENOUS ALENDRONATE IN POSTMENOPAUSAL WOMEN AND IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM AND PAGETS-DISEASE OF BONE [J].
ADAMI, S ;
ZAMBERLAN, N ;
MIAN, M ;
DORIZZI, R ;
ROSSINI, M ;
BRAGA, B ;
GATTI, D ;
BERTOLDO, F ;
LOCASCIO, V .
BONE AND MINERAL, 1994, 25 (02) :75-82
[7]   INFLUENCE OF DISODIUM ETIDRONATE ON CLINICAL AND LABORATORY MANIFESTATIONS OF PAGETS-DISEASE OF BONE (OSTEITIS DEFORMANS) [J].
ALTMAN, RD ;
JOHNSTON, CC ;
KHAIRI, MRA ;
WELLMAN, H ;
SERAFINI, AN ;
SANKEY, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (26) :1379-1384
[8]  
American Association of Clinical Endocrinologists Osteoporosis Task Force, 2001, Endocr Pract, V7, P293
[9]   PRELIMINARY-OBSERVATIONS OF A FORM OF COHERENCE THERAPY FOR OSTEOPOROSIS [J].
ANDERSON, C ;
CAPE, RDT ;
CRILLY, RG ;
HODSMAN, AB ;
WOLFE, BMJ .
CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (03) :341-343
[10]  
BASSETT CAL, 1969, LANCET, V2, P845
12345678910